In a multicenter study involving 217 subjects of European ancestry [106 patients with schizophrenia and 111 healthy subjects], we tested the hypothesis that the catechol-O-methyl transferase (COMT) Val 158Met and/or the brain-derived neurotrophic factor (BDNF) C 270T gene polymorphisms are associated with schizophrenia. The COMT and BDNF genotype and their allele distribution did not differ between patients with schizophrenia and healthy comparison subjects. These results do not support the hypothesis that the COMT Val 158Met or BDNF C 270T gene polymorphisms are associated with liability to schizophrenia.
COMT Val158Met and BDNF C270T polymorphisms in schizophrenia: a case-control study
GALDERISI, Silvana;MAJ, Mario;MUCCI, Armida;
2005
Abstract
In a multicenter study involving 217 subjects of European ancestry [106 patients with schizophrenia and 111 healthy subjects], we tested the hypothesis that the catechol-O-methyl transferase (COMT) Val 158Met and/or the brain-derived neurotrophic factor (BDNF) C 270T gene polymorphisms are associated with schizophrenia. The COMT and BDNF genotype and their allele distribution did not differ between patients with schizophrenia and healthy comparison subjects. These results do not support the hypothesis that the COMT Val 158Met or BDNF C 270T gene polymorphisms are associated with liability to schizophrenia.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
